Whisper
Lv2
140 积分
2023-05-19 加入
-
Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response
1个月前
已关闭
-
Anti‐drug antibodies of IL‐23 inhibitors for psoriasis: a systematic review
1个月前
已完结
-
A Pharmacometrics Model to Characterize a New Type of Target-Mediated Drug Disposition (TMDD) – Nonlinear Pharmacokinetics of Small-Molecule PF-07059013 Mediated By Its High-capacity Pharmacological Target Hemoglobin With Positive Cooperative Binding
1个月前
已完结
-
A Quantitative Systems Pharmacology Model of the Incretin Hormones GIP and GLP1, Glucagon, Glucose, Insulin, and the Small Molecule DPP-4 Inhibitor, Linagliptin
1个月前
已完结
-
A Quantitative Systems Pharmacology Model of the Incretin Hormones GIP and GLP1, Glucagon, Glucose, Insulin, and the Small Molecule DPP-4 Inhibitor, Linagliptin
1个月前
已完结
-
POS1550 IMPACT OF ORAL, SELECTIVE, ALLOSTERIC TYROSINE KINASE 2 (TYK2) INHIBITOR, DEUCRAVACITINIB, ON PSORIASIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 2 TRIAL
1个月前
已完结
-
The complement system in IgAN: mechanistic context for therapeutic opportunities
1个月前
已完结
-
IgA nephropathy
1个月前
已完结
-
Anifrolumab in systemic lupus erythematosus
2个月前
已完结
-
A multicenter, randomized, double-blinded, placebo-controlled, phase Ⅲ study evaluating the efficacy and safety of Xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
3个月前
已完结